Cystic Fibrosis Market Report: Trends, Forecast and Competitive Analysis to 2030
It will take 2-3 business days to deliver the report upon receipt the order if any customization is not there.
Cystic Fibrosis Trends and Forecast
The future of the global cystic fibrosis market looks promising with opportunities in the retail pharmacy & drug store, online pharmacy, and hospital pharmacy markets. The global cystic fibrosis market is expected to reach an estimated $10.9 billion by 2030 with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are growing cases of genomic mutations, rising patients preference for oral treatment, and augmenting number of pipeline patients.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cystic Fibrosis by Segment
The study includes a forecast for the global cystic fibrosis by drug class, route of administration, end use, and region.
Cystic Fibrosis Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cystic fibrosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cystic fibrosis companies profiled in this report include-
Lucintel forecasts that cystic fibrosis transmembrane conductance regulator is expected to witness highest growth over the forecast period due to its expanding use to improve cellular body function, enhance patients' quality of life, and lessen lung flare-ups and respiratory symptoms.
Online pharmacy is expected to witness highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period due to increasing number of people with various respiratory diseases, continous healthcare infrastructural advancement, and presence of key players in the region.
Features of the Global Cystic Fibrosis Market
Market Size Estimates: Cystic fibrosis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cystic fibrosis market size by various segments, such as by route of administration, end use, and region in terms of value ($B).
Regional Analysis: Cystic fibrosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different route of administrations, end uses, and regions for the cystic fibrosis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cystic fibrosis market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the cystic fibrosis market size?
Answer: The global cystic fibrosis market is expected to reach an estimated $10.9 billion by 2030.
Q.2 What is the growth forecast for cystic fibrosis market?
Answer: The global cystic fibrosis market is expected to grow with a CAGR of 8.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the cystic fibrosis market?
Answer: The major drivers for this market are growing cases of genomic mutations, rising patients preference for oral treatment, and augmenting number of pipeline patients.
Q4. What are the major segments for cystic fibrosis market?
Answer: The future of the cystic fibrosis market looks promising with opportunities in the retail pharmacy & drug store, online pharmacy, and hospital pharmacy markets.
Q5. Who are the key cystic fibrosis market companies?
Answer: Some of the key cystic fibrosis companies are as follows:
Answer: Lucintel forecasts that cystic fibrosis transmembrane conductance regulator is expected to witness highest growth over the forecast period due to its expanding use to improve cellular body function, enhance patients' quality of life, and lessen lung flare-ups and respiratory symptoms.
Q7. In cystic fibrosis market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing number of people with various respiratory diseases, continous healthcare infrastructural advancement, and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cystic fibrosis market by drug class (cystic fibrosis transmembrane conductance regulator (CFTR), bronchodilators, mucolytic, pancreatic enzyme supplement, and others), route of administration (oral and parenteral), end use (retail pharmacies & drug stores, online pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cystic Fibrosis Market, Cystic Fibrosis Market Size, Cystic Fibrosis Market Growth, Cystic Fibrosis Market Analysis, Cystic Fibrosis Market Report, Cystic Fibrosis Market Share, Cystic Fibrosis Market Trends, Cystic Fibrosis Market Forecast, Cystic Fibrosis Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Cystic Fibrosis Trends and Forecast
The future of the global cystic fibrosis market looks promising with opportunities in the retail pharmacy & drug store, online pharmacy, and hospital pharmacy markets. The global cystic fibrosis market is expected to reach an estimated $10.9 billion by 2030 with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are growing cases of genomic mutations, rising patients preference for oral treatment, and augmenting number of pipeline patients.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cystic Fibrosis by Segment
The study includes a forecast for the global cystic fibrosis by drug class, route of administration, end use, and region.
Cystic Fibrosis Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- Bronchodilators
- Mucolytic
- Pancreatic Enzyme Supplement
- Others
- Oral
- Parenteral
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Hospital Pharmacies
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cystic fibrosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cystic fibrosis companies profiled in this report include-
- Gilead Sciences
- Vertex Pharmaceuticals
- Novartis
- Allergan
- Abbvie
- Teva Pharmaceutical Industries
- F. Hoffmann-La Roche
- Pharmaxis
- Mylan
- Glaxosmithkline
Lucintel forecasts that cystic fibrosis transmembrane conductance regulator is expected to witness highest growth over the forecast period due to its expanding use to improve cellular body function, enhance patients' quality of life, and lessen lung flare-ups and respiratory symptoms.
Online pharmacy is expected to witness highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period due to increasing number of people with various respiratory diseases, continous healthcare infrastructural advancement, and presence of key players in the region.
Features of the Global Cystic Fibrosis Market
Market Size Estimates: Cystic fibrosis market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cystic fibrosis market size by various segments, such as by route of administration, end use, and region in terms of value ($B).
Regional Analysis: Cystic fibrosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different route of administrations, end uses, and regions for the cystic fibrosis market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cystic fibrosis market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the cystic fibrosis market size?
Answer: The global cystic fibrosis market is expected to reach an estimated $10.9 billion by 2030.
Q.2 What is the growth forecast for cystic fibrosis market?
Answer: The global cystic fibrosis market is expected to grow with a CAGR of 8.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the cystic fibrosis market?
Answer: The major drivers for this market are growing cases of genomic mutations, rising patients preference for oral treatment, and augmenting number of pipeline patients.
Q4. What are the major segments for cystic fibrosis market?
Answer: The future of the cystic fibrosis market looks promising with opportunities in the retail pharmacy & drug store, online pharmacy, and hospital pharmacy markets.
Q5. Who are the key cystic fibrosis market companies?
Answer: Some of the key cystic fibrosis companies are as follows:
- Gilead Sciences
- Vertex Pharmaceuticals
- Novartis
- Allergan
- AbbVie
- Teva Pharmaceutical Industries
- F. Hoffmann-La Roche
- Pharmaxis
- Mylan
- GlaxoSmithKline
Answer: Lucintel forecasts that cystic fibrosis transmembrane conductance regulator is expected to witness highest growth over the forecast period due to its expanding use to improve cellular body function, enhance patients' quality of life, and lessen lung flare-ups and respiratory symptoms.
Q7. In cystic fibrosis market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing number of people with various respiratory diseases, continous healthcare infrastructural advancement, and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cystic fibrosis market by drug class (cystic fibrosis transmembrane conductance regulator (CFTR), bronchodilators, mucolytic, pancreatic enzyme supplement, and others), route of administration (oral and parenteral), end use (retail pharmacies & drug stores, online pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cystic Fibrosis Market, Cystic Fibrosis Market Size, Cystic Fibrosis Market Growth, Cystic Fibrosis Market Analysis, Cystic Fibrosis Market Report, Cystic Fibrosis Market Share, Cystic Fibrosis Market Trends, Cystic Fibrosis Market Forecast, Cystic Fibrosis Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL CYSTIC FIBROSIS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cystic Fibrosis Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cystic Fibrosis Market by Drug Class
3.3.1: Cystic Fibrosis Transmembrane Conductance Regulator
3.3.2: Bronchodilators
3.3.3: Mucolytic
3.3.4: Pancreatic Enzyme Supplement
3.3.5: Others
3.4: Global Cystic Fibrosis Market by Route of Administration
3.4.1: Oral
3.4.2: Parenteral
3.5: Global Cystic Fibrosis Market by End Use
3.5.1: Retail Pharmacies & Drug Stores
3.5.2: Online Pharmacies
3.5.3: Hospital Pharmacies
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Cystic Fibrosis Market by Region
4.2: North American Cystic Fibrosis Market
4.2.2: North American Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
4.3: European Cystic Fibrosis Market
4.3.1: European Cystic Fibrosis Market by Drug Class: Cystic Fibrosis Transmembrane Conductance Regulator, Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others
4.3.2: European Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
4.4: APAC Cystic Fibrosis Market
4.4.1: APAC Cystic Fibrosis Market by Drug Class: Cystic Fibrosis Transmembrane Conductance Regulator, Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others
4.4.2: APAC Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
4.5: ROW Cystic Fibrosis Market
4.5.1: ROW Cystic Fibrosis Market by Drug Class: Cystic Fibrosis Transmembrane Conductance Regulator, Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others
4.5.2: ROW Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cystic Fibrosis Market by Drug Class
6.1.2: Growth Opportunities for the Global Cystic Fibrosis Market by Route of Administration
6.1.3: Growth Opportunities for the Global Cystic Fibrosis Market by End Use
6.1.4: Growth Opportunities for the Global Cystic Fibrosis Market by Region
6.2: Emerging Trends in the Global Cystic Fibrosis Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cystic Fibrosis Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cystic Fibrosis Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Gilead Sciences
7.2: Vertex Pharmaceuticals
7.3: Novartis
7.4: Allergan
7.5: AbbVie
7.6: Teva Pharmaceutical Industries
7.7: F. Hoffmann-La Roche
7.8: Pharmaxis
7.9: Mylan
7.10: GlaxoSmithKline
2. GLOBAL CYSTIC FIBROSIS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cystic Fibrosis Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cystic Fibrosis Market by Drug Class
3.3.1: Cystic Fibrosis Transmembrane Conductance Regulator
3.3.2: Bronchodilators
3.3.3: Mucolytic
3.3.4: Pancreatic Enzyme Supplement
3.3.5: Others
3.4: Global Cystic Fibrosis Market by Route of Administration
3.4.1: Oral
3.4.2: Parenteral
3.5: Global Cystic Fibrosis Market by End Use
3.5.1: Retail Pharmacies & Drug Stores
3.5.2: Online Pharmacies
3.5.3: Hospital Pharmacies
3.5.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Cystic Fibrosis Market by Region
4.2: North American Cystic Fibrosis Market
4.2.2: North American Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
4.3: European Cystic Fibrosis Market
4.3.1: European Cystic Fibrosis Market by Drug Class: Cystic Fibrosis Transmembrane Conductance Regulator, Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others
4.3.2: European Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
4.4: APAC Cystic Fibrosis Market
4.4.1: APAC Cystic Fibrosis Market by Drug Class: Cystic Fibrosis Transmembrane Conductance Regulator, Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others
4.4.2: APAC Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
4.5: ROW Cystic Fibrosis Market
4.5.1: ROW Cystic Fibrosis Market by Drug Class: Cystic Fibrosis Transmembrane Conductance Regulator, Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others
4.5.2: ROW Cystic Fibrosis Market by End Use: Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Cystic Fibrosis Market by Drug Class
6.1.2: Growth Opportunities for the Global Cystic Fibrosis Market by Route of Administration
6.1.3: Growth Opportunities for the Global Cystic Fibrosis Market by End Use
6.1.4: Growth Opportunities for the Global Cystic Fibrosis Market by Region
6.2: Emerging Trends in the Global Cystic Fibrosis Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Cystic Fibrosis Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cystic Fibrosis Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Gilead Sciences
7.2: Vertex Pharmaceuticals
7.3: Novartis
7.4: Allergan
7.5: AbbVie
7.6: Teva Pharmaceutical Industries
7.7: F. Hoffmann-La Roche
7.8: Pharmaxis
7.9: Mylan
7.10: GlaxoSmithKline
